2025 Annual Meeting | S23 - Innovations in Dementia Treatment
Program Materials Program Evaluations
| Jeffrey L. Cummings, MD, FAAN | Dr. Cummings has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia, Actinogen, Acumen, AlphaCognition, ALZpath, Aprinoia, AriBio, Artery, Biogen, Biohaven, BioVie, BioXcel, Bristol-Myers Squib, Cassava, Cerecin, Diadem, Eisai, GAP Foundation, GemVax, Janssen, Jocasta, Karuna, Lighthouse, Lilly, Lundbeck, LSP/eqt, Mangrove Therapeutics, Merck, NervGen, New Amsterdam, Novo Nordisk, Oligomerix, ONO, Optoceutics, Otsuka, Oxford Brain Diagnostics, Prothena, ReMYND, Roche, Sage Therapeutics, Signant Health, Simcere, sinaptica, Suven, TrueBinding, Vaxxinity, and Wren pharmaceutical, assessment, and investment companies. Dr. Cummings has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acadia, Biogen, Genentech, Grifols, Janssen, Karuna, Otsuka, reMYND, Roche, Signant Health. Dr. Cummings has stock in Artery, Vaxxinity, Behrens, Alzheon, MedAvante-Prophase, and Acumen. Dr. Cummings has received research support from NIH. Dr. Cummings has received research support from NIGMS. Dr. Cummings has received intellectual property interests from a discovery or technology relating to health care. |
| Kirk R. Daffner, MD, FAAN | The institution of Dr. Daffner has received research support from Azheimer's Association. The institution of Dr. Daffner has received research support from FUJIFILM. |
| Howard Feldman, MD, FAAN | The institution of Dr. Feldman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arrowhead Pharmaceuticals. The institution of Dr. Feldman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novo Nordisk. The institution of Dr. Feldman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen Research & Development LLC. The institution of Dr. Feldman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Banner/API. The institution of Dr. Feldman has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Tau Consortium. The institution of Dr. Feldman has received research support from US National Institute of Health NIH/NIA. The institution of Dr. Feldman has received research support from US National Institute of Health NIH/NIA. The institution of Dr. Feldman has received research support from Vivoryon Therapeutics. The institution of Dr. Feldman has received research support from US National Institute of Health NIH/NIA. The institution of Dr. Feldman has received research support from US National Institute of Health NIH/NIA. The institution of Dr. Feldman has received research support from LuMind Foundation. The institution of Dr. Feldman has received research support from US National Institute of Health NIH/NIA. The institution of Dr. Feldman has received research support from Biohaven Pharmaceuticals. The institution of Dr. Feldman has received research support from UC San Diego School of Medicine Brain Health Support Program & Sanford Institute for Empathy and Compassion. The institution of Dr. Feldman has received research support from US National Institute of Health NIH/NIA. The institution of Dr. Feldman has received research support from US National Institute of Health NIH/NIA. Dr. Feldman has received intellectual property interests from a discovery or technology relating to health care. Dr. Feldman has a non-compensated relationship as a Medical Advisory Council with Association for Frontotemporal Degeneration (AFTD) that is relevant to AAN interests or activities. Dr. Feldman has a non-compensated relationship as a International Scientific Advisory Board with Translating Research in Elder Care (TREC) that is relevant to AAN interests or activities. |
| Lynn D. Kramer, MD, FAAN | Dr. Kramer has received personal compensation for serving as an employee of Eisai Inc. Dr. Kramer has received personal compensation in the range of $1,000,000+ for serving as an officer or member of the Board of Directors for Eisai Co., Ltd.. |
| Mario F. Mendez, MD, PhD, FAAN | Dr. Mendez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medical 好色先生 Speakers' Bureau. Dr. Mendez has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for UpToDate. The institution of Dr. Mendez has received research support from NIH. Dr. Mendez has received publishing royalties from a publication relating to health care. |
| Thomas M. Wisniewski, MD | Dr. Wisniewski has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers in Aging Neuroscience. The institution of Dr. Wisniewski has received research support from the National Institute of Aging. Dr. Wisniewski has received intellectual property interests from a discovery or technology relating to health care. |
| Steven M. Hersch, MD, PhD | Dr. Hersch has received personal compensation for serving as an employee of Eisai Inc.. Dr. Hersch has stock in Voyager Therapeutics. The institution of an immediate family member of Dr. Hersch has received research support from NIH. Dr. Hersch has received intellectual property interests from a discovery or technology relating to health care. |
| R S. Turner, MD, PhD, FAAN | Dr. Turner has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Re:Cognition Health. |
| Michael C. Irizarry, MD | Dr. Irizarry has received personal compensation for serving as an employee of Eisai, Inc.. |
| Peter J. McAllister, MD, FAAN | Dr. McAllister has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for lilly. Dr. McAllister has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for abbvie. Dr. McAllister has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for lundbeck. |
| Stephen H. Pasternak, MD, PhD | Dr. Pasternak has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lilly. Dr. Pasternak has stock in Zywie Bio LLC. The institution of Dr. Pasternak has received research support from Zywie Bio LLC. Dr. Pasternak has received intellectual property interests from a discovery or technology relating to health care. |
| Ging-Yuek R. Hsiung, MD, FAAN | Dr. Hsiung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Dr. Hsiung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. The institution of Dr. Hsiung has received research support from CIHR. The institution of Dr. Hsiung has received research support from NIH. The institution of Dr. Hsiung has received research support from Eli Lilly. The institution of Dr. Hsiung has received research support from Biogen. |
| Fernando L. Pagan, MD, FAAN | Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acorda. Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Adamas. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merz. Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Kyowa Kirin. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sunovion. Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for US World Meds. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Supernus. Dr. Pagan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Acorda. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Adamas. Dr. Pagan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amneal. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sunovion. Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Pagan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurocrine. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sunovion. Dr. Pagan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Supernus. Dr. Pagan has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Clinical Parkinsonism and related Disorders. Dr. Pagan has stock in Keiferx. The institution of Dr. Pagan has received research support from US World Meds. The institution of Dr. Pagan has received research support from Novartis. |
| Jack W. Tsao, MD, DPhil, FAAN | The institution of Dr. Tsao has received research support from NIH. The institution of Dr. Tsao has received research support from US Army. Dr. Tsao has received publishing royalties from a publication relating to health care. Dr. Tsao has received personal compensation in the range of $500-$4,999 for serving as a Study Section Member with NIH. |
| Adam L. Boxer, MD, PhD | An immediate family member of Dr. Boxer has received personal compensation for serving as an employee of Kaiser Permanente. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ono. Dr. Boxer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Oscotec. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Boxer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Arrowhead. Dr. Boxer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine Biosciences. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Switch. Dr. Boxer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Arvinas. Dr. Boxer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alector. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Boxer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Transposon. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen . Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Boxer has stock in Alector. Dr. Boxer has stock in Arvinas. Dr. Boxer has stock in Neurovanda. The institution of Dr. Boxer has received research support from Biogen. The institution of Dr. Boxer has received research support from Eisai. The institution of Dr. Boxer has received research support from Regeneron. The institution of Dr. Boxer has received research support from NIH. The institution of Dr. Boxer has received research support from Bluefield Project-5. Dr. Boxer has received research support from Rainwater Charitable Foundation. Dr. Boxer has received research support from GHR Foundation. Dr. Boxer has received intellectual property interests from a discovery or technology relating to health care. |
| Martin J. Sadowski, MD, PhD | The institution of Dr. Sadowski has received research support from National Institute on Aging. The institution of Dr. Sadowski has received research support from Biogen. The institution of Dr. Sadowski has received research support from Novartis. The institution of Dr. Sadowski has received research support from Janssen Research and Development. The institution of Dr. Sadowski has received research support from Eisai. The institution of Dr. Sadowski has received research support from TauRx Therapeutics Ltd. The institution of Dr. Sadowski has received research support from Suven Life Sciences Ltd.. The institution of Dr. Sadowski has received research support from Merck Sharp & Dohme Corp.. The institution of Dr. Sadowski has received research support from Alzheimer's Disease Cooperative Study. The institution of Dr. Sadowski has received research support from Neurotrack Technologies Inc.. Dr. Sadowski has received intellectual property interests from a discovery or technology relating to health care. Dr. Sadowski has received personal compensation in the range of $100,000-$499,999 for serving as a VA Physician with Veterans' Affairs. |
| John R. Sims, MD | Dr. Sims has received personal compensation for serving as an employee of Eli Lilly and Company. Dr. Sims has stock in Eli Lilly and Company. |
| Carmela Tartaglia, MD | Dr. Tartaglia has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Dr. Tartaglia has received research support from NIH. The institution of Dr. Tartaglia has received research support from University of Toronto. |
| Bradford Dickerson, MD, FAAN | Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arkuda. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lantheus. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Dickerson has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arkuda. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acadia. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Dickerson has received publishing royalties from a publication relating to health care. Dr. Dickerson has received publishing royalties from a publication relating to health care. |
| Erin G. Doty, MD | Dr. Doty has received personal compensation for serving as an employee of Eli Lilly and Company, USA. Dr. Doty has stock in Eli Lilly and Company, USA. |
| Elizabeth Finger, MD, FAAN | Dr. Finger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vigil Neuro. Dr. Finger has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Denali Therapeutics. The institution of Dr. Finger has received research support from CIHR. The institution of Dr. Finger has received research support from Physician Servcices Incorporated. The institution of Dr. Finger has received research support from Weston Foundation. Dr. Finger has received personal compensation in the range of $500-$4,999 for serving as a Annual Meeting Course Director with 好色先生. |
| Mark C. Eldaief, MD | No disclosure on file |
| Mario Masellis, MD | Dr. Masellis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arkuda Therapeutics. Dr. Masellis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis. Dr. Masellis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alector. Dr. Masellis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Wave Life Sciences. The institution of Dr. Masellis has received research support from Canadian Institutes of Health Research. The institution of Dr. Masellis has received research support from Ontario Brain Institute. The institution of Dr. Masellis has received research support from Weston Brain Institute. The institution of Dr. Masellis has received research support from Washington University. The institution of Dr. Masellis has received research support from Alector. Dr. Masellis has received publishing royalties from a publication relating to health care. |
| Robert Laforce, Jr., MD, PhD | Dr. Laforce has nothing to disclose. |
| Anton P. Porsteinsson, MD | Dr. Porsteinsson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ONO Pharmaceuticals. Dr. Porsteinsson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Porsteinsson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Porsteinsson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for IQVIA. Dr. Porsteinsson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for WebMD. Dr. Porsteinsson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Porsteinsson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Otsuka. Dr. Porsteinsson has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acadia. Dr. Porsteinsson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Functional Neuromodulation. Dr. Porsteinsson has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Xenon Pharmaceuticals. Dr. Porsteinsson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Porsteinsson has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cognitive Research Corporation. Dr. Porsteinsson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Athira. Dr. Porsteinsson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. The institution of Dr. Porsteinsson has received research support from Alector. The institution of Dr. Porsteinsson has received research support from Eisai. The institution of Dr. Porsteinsson has received research support from Eli Lilly. The institution of Dr. Porsteinsson has received research support from Athira. The institution of Dr. Porsteinsson has received research support from Genentech/Roche. The institution of Dr. Porsteinsson has received research support from Cassava. The institution of Dr. Porsteinsson has received research support from Vaccinex. |
| Jennifer Zimmer, MD | Dr. Zimmer has received personal compensation for serving as an employee of Eli Lilly & Company. Dr. Zimmer has stock in Eli Lilly & Company. |
| Mark A. Mintun, MD | Dr. Mintun has received personal compensation for serving as an employee of Eli Lilly & Co. |
| Kimiko Domoto-Reilly, MD | Dr. Domoto-Reilly has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MedBridge. The institution of Dr. Domoto-Reilly has received research support from Lawson Health Research Institute. The institution of Dr. Domoto-Reilly has received research support from NIH. The institution of Dr. Domoto-Reilly has received research support from Biogen. The institution of Dr. Domoto-Reilly has received research support from Lewy Body Dementia Association. The institution of Dr. Domoto-Reilly has received research support from Garvey Institute for Brain Health Solutions. The institution of Dr. Domoto-Reilly has received research support from Cognition Therapeutics. The institution of Dr. Domoto-Reilly has received research support from Takayama Family. |
| Joel Salinas, MD, MBA, MSc, FAAN | Dr. Salinas has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eisai, Inc. Dr. Salinas has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eli Lilly, Inc. Dr. Salinas has stock in Isaac Health. |
| Charbel E. Moussa, PhD, MB | Dr. Moussa has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for KeifeRX LLC. Dr. Moussa has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sun Pharmaceuticals Research Industry. Dr. Moussa has received stock or an ownership interest from Orphan Therapeutics. The institution of Dr. Moussa has received research support from NIA. The institution of Dr. Moussa has received research support from Sun Pharmaceuticals Research Industry. The institution of Dr. Moussa has received research support from Alzheimer's Association . Dr. Moussa has received intellectual property interests from a discovery or technology relating to health care. Dr. Moussa has received intellectual property interests from a discovery or technology relating to health care. Dr. Moussa has received publishing royalties from a publication relating to health care. Dr. Moussa has received personal compensation in the range of $500-$4,999 for serving as a Grant reviewer with DG Information Technology. Dr. Moussa has received personal compensation in the range of $0-$499 for serving as a Peer Reviews with National Institutes of Health. |
| Seth Gale, MD | Dr. Gale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cowen. The institution of Dr. Gale has received research support from Brigham And Women's Hospital. |
| Jared R. Brosch, MD | Dr. Brosch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Brosch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Brosch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Brosch has stock in Monument Biosciences. The institution of Dr. Brosch has received research support from Alnylam Pharmaceuticals. The institution of Dr. Brosch has received research support from Athira Pharmaceuticals. The institution of Dr. Brosch has received research support from Biogen. The institution of Dr. Brosch has received research support from EISAI. The institution of Dr. Brosch has received research support from F. Hoffman La-Roche. The institution of Dr. Brosch has received research support from University of Southern California. The institution of Dr. Brosch has received research support from Washington University. Dr. Brosch has received publishing royalties from a publication relating to health care. |
| Arjun V. Masurkar, MD | The institution of Dr. Masurkar has received research support from NIH. The institution of Dr. Masurkar has received research support from Alzheimer's Association. The institution of Dr. Masurkar has received research support from BrightFocus Foundation. Dr. Masurkar has received personal compensation in the range of $500-$4,999 for serving as a IRGP Advisory Council Member with Alzheimer's Association. Dr. Masurkar has a non-compensated relationship as a Steering Committee Member with Alzheimer's Disease Cooperative Study that is relevant to AAN interests or activities. |
| Irina Skylar-Scott, MD | An immediate family member of Dr. Skylar-Scott has received personal compensation in the range of $500-$4,999 for serving as a Consultant for 3D Systems. Dr. Skylar-Scott has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for PeerView/Lilly. The institution of an immediate family member of Dr. Skylar-Scott has received research support from The Chan Zuckerberg Initiative. Dr. Skylar-Scott has received research support from Biogen. An immediate family member of Dr. Skylar-Scott has received intellectual property interests from a discovery or technology relating to health care. Dr. Skylar-Scott has received publishing royalties from a publication relating to health care. |
| Raghavendra Vasudeva, PhD | Dr. Vasudeva has received personal compensation for serving as an employee of Lilly. Dr. Vasudeva has stock in Lilly. |
| Chiadi U. Onyike, MD | Dr. Onyike has received personal compensation for serving as an employee of Rainwater Foundation. Dr. Onyike has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acadia Pharmaceuticals . Dr. Onyike has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Reata Pharmaceuticals. Dr. Onyike has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Goodell, DeVries, Leech & Dann. The institution of Dr. Onyike has received research support from Alector. |
| Yasar A. Torres-Yaghi, MD | Dr. Torres-Yaghi has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Acorda. Dr. Torres-Yaghi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Torres-Yaghi has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amneal. Dr. Torres-Yaghi has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbott. Dr. Torres-Yaghi has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Kyowa Kirin. Dr. Torres-Yaghi has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva. Dr. Torres-Yaghi has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sunovion . |
| Travis J. Urban, MD | Dr. Urban has nothing to disclose. |
| Megan Quimby | Ms. Quimby has nothing to disclose. |
| Larisa Reyderman | Larisa Reyderman has nothing to disclose. |
| Kristen Watkins, MD | Dr. Watkins has nothing to disclose. |
| Neguine Rezaii, MD | Dr. Rezaii has nothing to disclose. |
| Thiago Paranhos, Sr., MD | Mr. Paranhos has nothing to disclose. |
| Philip T. Kuball, MD | Dr. Kuball has nothing to disclose. |
| Ming Lu | Ming Lu has received personal compensation for serving as an employee of Eli Lilly and Company. Ming Lu has stock in Eli Lilly and Company. |
| Shobha Dhadda | No disclosure on file |
| Cynthia Evans | Cynthia Evans has received personal compensation for serving as an employee of Eli Lilly & Company. Cynthia Evans has stock in Eli Lilly & Company. |
| Emily Collins | Emily Collins has received personal compensation for serving as an employee of Eli Lilly. Emily Collins has stock in Eli Lilly. |
| Edward Huey | The institution of Edward Huey has received research support from NIH. |
| Advaith N. Rao, MBBS | Mr. Rao has nothing to disclose. |
| Giuseppe Esposito, MD, MBA | Dr. Esposito has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lily. Dr. Esposito has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai. Dr. Esposito has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Telix. Dr. Esposito has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Blue Earth Diagnostics. Dr. Esposito has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Progenics. Dr. Esposito has received research support from Regeneron. Dr. Esposito has received personal compensation in the range of $5,000-$9,999 for serving as a Associate research with Progenics. Dr. Esposito has received personal compensation in the range of $500-$4,999 for serving as a Associate research with Morphosys. |
| Barbara M. Wilmarth, NP | Mrs. Wilmarth has nothing to disclose. |
| Kristy K. Coleman | Ms. Coleman has nothing to disclose. |
| Ramiro Ruiz-Garcia, MD | Dr. Ruiz-Garcia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for CARNOT. |
| Anna McGlothlin, PhD | Dr. McGlothlin has received personal compensation for serving as an employee of Berry Consultants. |
| Miguel Restrepo Martínez, MD | Dr. Restrepo Martínez has nothing to disclose. |
| Sachin Pandey, MD | Dr. Pandey has nothing to disclose. |
| Simon Ducharme, MD | Dr. Ducharme has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eisai. Dr. Ducharme has received personal compensation in the range of $500-$4,999 for serving as a Consultant for QuRALIS. Dr. Ducharme has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Ducharme has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for IntelGenX. An immediate family member of Dr. Ducharme has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aviado Bio. Dr. Ducharme has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eisai. Dr. Ducharme has stock in AFX Medical Inc. The institution of Dr. Ducharme has received research support from CIHR. The institution of Dr. Ducharme has received research support from Alzheimer Drug Discovery Foundation. The institution of Dr. Ducharme has received research support from Biogen. The institution of Dr. Ducharme has received research support from Novo Nordisk. The institution of Dr. Ducharme has received research support from Passage Bio. The institution of Dr. Ducharme has received research support from Janssen. The institution of Dr. Ducharme has received research support from Alnylam. The institution of Dr. Ducharme has received research support from Innodem Neurosciences. |
| Michelle Detry, PhD | Dr. Detry has received personal compensation for serving as an employee of Berry Consultants. |
| Michael S. Mayich, MD | Dr. Mayich has nothing to disclose. |
| Jasdip Singh, PharmD | Dr. Singh has received personal compensation for serving as an employee of Eli Lilly and Company. Dr. Singh has stock in Eli Lilly and Company. |
| Shradha Chervittara Karaveetil, MBBS | Miss Chervittara Karaveetil has nothing to disclose. |
| Arnaud Charil, PhD | Dr. Charil has received personal compensation for serving as an employee of Eisai Inc.. |
| Shreya Narayan | Ms. Narayan has nothing to disclose. |
| Se Ryeong Jang, MPH | Miss Jang has received personal compensation for serving as an employee of Eisai Inc. |
| Pavan Kumara Kasam Shiva, MBBS | Mr. Kasam Shiva has nothing to disclose. |
| Vinay C. Chandramouli Bellur, MBBS | Mr. Chandramouli Bellur has nothing to disclose. |
| Ananya Prasad, MBBS | Miss Prasad has nothing to disclose. |
| Anmol Rao | Mr. Rao has nothing to disclose. |
| Era Gupta, MBBS | Dr. Gupta has nothing to disclose. |
| Erin O. Wong, PhD | Dr. Wong has received personal compensation for serving as an employee of EVERSANA. |
| Laura Pastor, MSc | Mrs. Pastor has received personal compensation for serving as an employee of EVERSANA. |
| Fan Yang, PhD | Ms. Yang has nothing to disclose. |
| Brittany M. McFeeley | Mrs. McFeeley has nothing to disclose. |
| Kayla Riera, BS | Miss Riera has nothing to disclose. |
| George Ryan Ghorayeb, MA | Mr. Ghorayeb has nothing to disclose. |
| Isabel Stobin, BS | Miss Stobin has received research support from National Science Foundation. |
| Yuta Katsumi, PhD | The institution of Dr. Katsumi has received research support from the National Institute on Aging. The institution of Dr. Katsumi has received research support from the Alzheimer's Association. |
| Anna Du | Miss Du has received personal compensation for serving as an employee of Wesleyan University. |
| Nneka Watson, MS, CCC-SLP | Ms. Watson has nothing to disclose. |
| Bonnie Wong, PhD | Dr. Wong has nothing to disclose. |
| Alexandra Touroutoglou, PhD | Dr. Touroutoglou has nothing to disclose. |
| Ivelina Gueorguieva, PhD | Dr. Gueorguieva has stock in Eli Lilly. |
| Nathan a. Herrmann, MD | Prof. Herrmann has nothing to disclose. |
| David Trueman | The institution of Mr. Trueman has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Eisai Inc. |
| Sergey Shcherbinin, PhD | Dr. Shcherbinin has received personal compensation for serving as an employee of Eli Lilly and Company. Dr. Shcherbinin has stock in Eli Lilly and Company. Dr. Shcherbinin has received intellectual property interests from a discovery or technology relating to health care. |
| Daisy Hochberg, MS | An immediate family member of Mrs. Hochberg has received research support from Department of Veterans Affairs. An immediate family member of Mrs. Hochberg has received intellectual property interests from a discovery or technology relating to health care. |
| Oliver Burn | The institution of Mr. Burn has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Eisai Inc. |
| Natalia Penner, PhD | Dr. Penner has received personal compensation for serving as an employee of eisai. Dr. Penner has received personal compensation for serving as an employee of Zentalis. Dr. Penner has received personal compensation for serving as an employee of Biogen. Dr. Penner has stock in Biogen. |
| Kate Molloy | The institution of Ms. Molloy has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Eisai Inc. |
| Adam Haynes | Mr. Haynes has received personal compensation for serving as an employee of Eisai Canada. |
| Kim Castellano, MSc | Mrs. Castellano has nothing to disclose. |
| carolyn bodnar | Ms. bodnar has received personal compensation for serving as an employee of Eisai Europe Ltd. |
| Simon Rothwell, PhD | Dr. Rothwell has received personal compensation for serving as an employee of Eisai. |
| Kay Hoong Chow | Mr. Chow has received personal compensation for serving as an employee of Eli Lilly and Company. Mr. Chow has stock in Eli Lilly and Company. |
| Pratik Bhagunde, PhD | Dr. Bhagunde has received personal compensation for serving as an employee of Eisai. |
| Chloe Stewart, PhD | Dr. Stewart has nothing to disclose. |
| Scott Berry | No disclosure on file |
| Anna Bosse | No disclosure on file |
| Bryan Dias | No disclosure on file |